T1	Participants 588 602	clinical trial
T2	Participants 190 223	all cats within an affected group
T3	Participants 429 470	Chlamydia trachomatis infection in humans
T4	Participants 723 728	cats.
T5	Participants 960 964	cats
T6	Participants 1032 1057	chronically infected cats
